将来の認知症負担に対する修正可能なリスク因子の減少の影響:マイクロシミュレーションモデリング研究
Chiara C Brück1, Koen de Nijs2, M Arfan Ikram3
1Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands. c.bruck@erasmusmc.nl.
European journal of epidemiology
|August 23, 2025
まとめ
喫煙や高血圧などの 変えられる危険因子を減らすことで 認知症の症例が減り 認知症のない寿命が延びるのです しかし 寿命が延びると 認知症の症例が増えるかもしれません
科学分野:
- 神経科学
- 流行病学について
- 公衆衛生
背景:
- 認知症の30%から50%は 修正可能なリスク因子と関連しています
- 認知症リスク削減戦略の集団レベルでの影響は不明である.
- 正確なモデリングには 平均寿命の変化と リスク因子の共存を考慮する必要があります
研究 の 目的:
- 中年期における高血圧と高齢者の喫煙が 認知症と死亡率に与える影響を評価する.
- 部分的または完全な排除から様々なリスク因子削減シナリオをモデル化します.
- 認知症の発生率,罹患率,症例数,認知症と無認知症の寿命に対する影響を評価する.
主な方法:
- MISCAN-Dementiaマイクロシミュレーションモデルを使用しました.
- 完全排除を含む高血圧と喫煙に対するシミュレーション介入
- 様々な削減レベルと人口グループで分析された結果
主要な成果:
- モデル化されたすべてのリスク因子の減少は,認知症の発生率,罹患率,症例数を減少させた.
- 高血圧では1. 1%,高血圧では3. 3%,喫煙では1. 4%,高血圧では2. 5%の減少が見られた.
- 認知症のない寿命が増加した一方で 寿命が延びたため 認知症の症例がわずかに増加しました
結論:
- 認知症のリスクを減らす戦略は,特に喫煙と高血圧の場合は,認知症のない寿命を延ばす上で大きな利益をもたらします.
- 認知症の症例を わずかに減らすことは可能である.
- これらの介入の長期的な影響を評価する際には,期待寿命の並行的な変化を考慮することが重要です.
関連する概念動画
01:30Dementia
165
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
165
01:26Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
01:30Coronary Artery Disease I: Introduction
55
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
55
01:26Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
01:26Coronary Artery Disease IV: Preventive Measures
32
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
32